Preventing gaps when switching contraceptives

American Family Physician

Volumn 83, Issue 5, 2011, Pages 567-570

  Lesnewski, Ruth ^a   Prine, Linda ^b   Ginzburg, Regina ^c  

^a Beth Israel Residency in Urban Family Practice   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c John's University College of Pharmacy and Allied Health Professions   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETONOGESTREL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; SPERMICIDAL AGENT; ORAL CONTRACEPTIVE AGENT;

ADVERSE OUTCOME; ARTICLE; ATTITUDE TO HEALTH; BARRIER CONTRACEPTION; CONDOM; CONTRACEPTION; COST BENEFIT ANALYSIS; FAMILY PLANNING; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; SEXUAL BEHAVIOR; SEXUAL COUNSELING; VAGINA RING; WOMEN'S HEALTH; DRUG EFFECT; FEMALE; PREGNANCY; REVIEW; UNWANTED PREGNANCY;

CONTRACEPTIVES, ORAL; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; PREGNANCY; PREGNANCY, UNWANTED; PROGESTINS;

EID: 79955978890     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Per-spect Sex Reprod Health. 2006;38(2):90-96.
2. U.S. Department of Health and Human Services. Progress review: family planning. http://www.healthypeople. gov/2010/data/2010prog/focus09/2008Focus09.pdf. Accessed February 9, 2011.
3. Landry DJ, Wei J, Frost JJ. Public and private providers' involvement in improving their patients' contraceptive use. Contraception. 2008;78(1):42-51.
4. Frost JJ, Darroch JE, Remez L. Improving contraceptive use in the United States. Issues Brief (Alan Guttmacher Inst). 2008;(1):1-8.
5. Zieman M, Hatcher RA, Swiak C, Darney PD, Crenin MD, Stosur HR. A Pocket Guide to Managing Contraception. 9th ed. Tiger, Ga.: Bridging the Gap Foundation; 2007.
6. Combination oral contraceptives and the risk of venous thromboembolism. Med Lett Drugs Ther. 2010;52(1334):23-24.
7. World Health Organization. Department of Reproductive Health and Research. Selected Practice Recommendations for Contraceptive Use. 2nd ed. Geneva, Switzerland: World Health Organization; 2004.
8. U.S. National Library of Medicine. DailyMed. Ortho Evra (norelgestromin and ethinyl estradiol) patch, extended release. http://dailymed.nlm.nih.gov/. Accessed October 15, 2010.
9. Guilbert E, Black A, Dunn S, et al. Missed hormonal contraceptives: new recommendations. J Obstet Gynaecol Can. 2008;30(11):1050-1062, 1063-1077.
10. U.S. National Library of Medicine. DailyMed. Nuvaring (etonogestrel and ethinyl estradiol) insert, extended release. http://dailymed.nlm.nih.gov/. Accessed October 15, 2010.
11. Abrams LS, et al. Pharmacokinetic overview of Ortho Evra/Evra. Fertil Steril. 2002;77(2 suppl 2):S3-S12.
12. Abrams LS, et al. Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches. J Clin Pharmacol. 2001;41(11):1232-1237.
13. Timmer CJ, Mulders TM. Pharmacokinetics of etono-gestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet. 2000;39(3):233-242.
14. U.S. National Library of Medicine. DailyMed. Mirena (levonorgestrel) intrauterine device. http://dailymed.nlm.nih.gov/. Accessed October 15, 2010.
15. U.S. National Library of Medicine. DailyMed. Depo-Provera (medroxyprogesterone acetate) injection, suspension. http://dailymed.nlm.nih.gov/. Accessed October 15, 2010.
16. Bennink HJ. The pharmacokinetics and pharmacody-namics of Implanon, a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care. 2000;5(suppl 2):12-20.
17. Tadesse E. Return of fertility after an IUD removal for planned pregnancy: a six year prospective study. East Afr Med J. 1996;73(3):169-171.
18. World Health Organization. Selected practice recommendations for contraceptive use: 2008 update. http:// whqlibdoc.who.int/hq/2008/WHO_RHR_08.17_eng.pdf. Accessed October 15, 2010.
19. Cheng L, et al. Interventions for emergency contraception. Cochrane Database Syst Rev. 2008;(2):CD001324.
20. Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999;181(5 pt 1):1263-1269.